John B. Green, Chief Financial Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 40,938 shares at $19.95 ($817K) on 2020-04-07, disclosed to the SEC on 2020-04-09.
Open-market sale of $817k DRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.95 | 20,469 | $408K | 50.0% |
| 2 | $19.95 | 20,469 | $408K | 50.0% |
| Total | $19.95 avg | 40,938 | $817K | 100% |
| Filing → |
| DRNA | SELL | 2019-11-27 | $312K | — | Filing → |
| DRNA | SELL | 2019-11-20 | $263K | — | Filing → |
| DRNA | SELL | 2019-11-15 | $71K | — | Filing → |